Retrospective cohort study assesses recurrence rates and compares four risk stratification models, highlighting significant predictive factors.
Solitary fibrous tumors of the pleura (SFTP) are rare fibroblastic mesenchymal tumors with usually a benign histologic profile. However, 10 to 30% will recur or metastasize. Our study aimed to determine the recurrence rate of SFTP, compare the effectiveness of four major risk stratification models, and analyze recurrence risk factors. We conducted a bi-centric retrospective cohort study between 2003 and 2022 on resected SFTP. Clinical, surgical procedures and pathologic reports were examined. Patients were risk-stratified by using four prediction models: de Perrot, Tapias, modified Demicco, and G-score. We included 96 patients with 49 female (51%) and a median age of 67 years-old. Median follow-up was 6 years. Sixteen patients presented recurrence/metastasis (16,7%). The 5-years/10-years/15-years freedom from recurrence rates were 88.4%/65%/63.2%. Risk factors for recurrence were age, paraneoplastic syndrome, tumour size ≥ 10 cm, extended resection, Ki67 index ≥10%, hypercellularity, pleomorphism, necrosis, and ≥ 4 mitotic figures. The 5-years/10-years/15-years OS were 93.9%/83.4%/83.4% respectively. During follow-up, a total of 9 patients (9.3%) died with 6 related disease death (66%). Survival was significantly worse in patients with recurrence (HR = 12.5 [95% CI = 2.58 to 61.0], p < 0.0001). Comparison of the four risk stratification models revealed that the modified Demicco score was the most accurate to predict recurrence (AUC= 0.83 95% CI: 0.74-0.91). Recurrence of SFTP after surgical complete resection occurs in few patients and is associated with an increased mortality. The modified Demicco score is the most accurate to predict recurrence.
No takes yet. Share an insight, caveat, or question.
Gagnepain et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: